Press Releases
TJP Labs Press releases
TJP Labs Inc. Receives FDA Acceptance For Premarket Tobacco Product Application (PMTA)
(“TJP Labs”) is proud to announce the acceptance of its Premarket Tobacco Product Application (PMTA) submission by the U.S. Food and Drug Administration for its brand, L!X nicotine pouches.
TJP LABS INC. AMENDS ITS DRUG ESTABLISHMENT LICENSE AND ACHIEVES APPROVAL FOR ACTIVE PHARMACEUTICAL INGREDIENTS
TJP Labs announced that after completing a thorough regulatory assessment and meeting all GMP requirements, it received a notice of compliance for Active Pharmaceutical Ingredients (API) following an audit by the Health Canada Drug GMP Inspection Program. (“NAI”)
TJP LABS INC. IS GRANTED DRUG ESTABLISHMENT LICENSING (DEL) BY HEALTH CANADA.
After completing a thorough regulatory assessment and meeting all GMP requirements, Health Canada has granted TJP Labs Inc. a Drug Establishment License (DEL).
TJP LABS COMPLETES MULTI-MILLION DOLLAR INVESTMENT ROUND TO CONTINUE GLOBAL EXPANSION INTO MODERN ORAL NICOTINE MANUFACTURING
TJP Labs Inc. (“TJP Labs”), one of North America’s leading full-service contract manufacturers of next-generation nicotine products, announced its launch of Canada’s first modern oral nicotine contract manufacturing facility for buccal nicotine pouches.
TJP LABS ANNOUNCES ACQUISITION OF DRUG ESTABLISHMENT LICENSED FACILITY FROM NORTH AMERICAN INGREDIENTS
TJP Labs Inc. (“TJP Labs”), one of North America’s leading full-service contract manufacturers of next-generation nicotine products, announced today that it has, through a wholly owned subsidiary, acquired certain assets of North American Ingredients Inc. (“NAI”)